|
TRIPTERINE | ||
PRODUCT IDENTIFICATION | ||
CAS NO. | 34157-83-0 |
|
EINECS NO. | ||
FORMULA | C29H38O4 | |
MOL WT. | 450.61 | |
H.S. CODE |
2918.99.5000 | |
TOXICITY |
||
SYNONYMS | Tripterine; Tripterin; Celastrol; | |
(2R,4aS,6aS,6aR,14bR)-10-hydroxy-2,4a,6a,6a,9,14a-hexamethyl-11-oxo-1,3,4,5,6, 13,14,14b- octahydropicene-2-carboxylic acid; (20alpha)-3-Hydroxy-2-oxo- D:A-Friedo-24- noroleana- 1(10),3,5,7- tetraen-29-oic acid; 10-Hydroxy-2,4a,6a,9,12b,14a-hexamethyl-11-oxo-1,2,3,4,4a, 5,6,6a,11,12b, 13,14, 14a,14b- tetradecahydropicene-2-carboxylic acid; 3-Hydroxy-24-nor-2-oxo-1(10),3,5,7- friedelatetraen- 29-oic acid; | ||
SMILES |
C12=CC(=O)C(=C(C2=CC=C2[C@]1(CC[C@@]1([C@@]2(CC[C@ @]2([C @H] 1C[C@](C(=O)O)(CC2)C)C)C)C)C)C)O | |
CLASSIFICATION |
Triterpenoid, Anti-Inflammatory | |
EXTRA NOTES |
A pentacyclic triterpenoid that is 24,25,26-trinoroleana-1(10),3,5,7- tetraen- 29-oic acid bearing an oxo substituent at position 2, a hydroxy substituent at position 3 and two methyl groups at positions 9 and 13. An antioxidant and anti-inflammatory agent. Potently inhibits lipid peroxidation in mitochondria and inhibits TNF-α-induced NFκB activation. Also shown to inhibit topoisomerase II activity in vitro (IC50 = 7.41 μM). (ChEBI) Isolated from Tripterygium wilfordii; potent inhibitory activity on both Kir2.1 and ERG1 potassium channels, leading to long qt syndrome. | |
PHYSICAL AND CHEMICAL PROPERTIES | ||
PHYSICAL STATE |
red crystalline powder | |
MELTING POINT |
190~ 195 C | |
BOILING POINT | ||
SPECIFIC GRAVITY | ||
SOLUBILITY IN WATER |
Insoluble | |
SOLVENT SOLUBILITY |
Soluble in most nonpolar solvents, DMSO, ethanol. | |
pH | ||
VAPOR DENSITY | ||
AUTOIGNITION |
| |
NFPA RATINGS |
Health Hazard: 2 Fire: 0 Reactivity Hazard:0 | |
REFRACTIVE INDEX |
| |
FLASH POINT |
| |
STABILITY | Stable under ordinary conditions. | |
GENERAL DESCRIPTION & EXTERNAL LINKS | ||
Wikipedia Linking - Quinone methide Google Scholar Search - Celastrol Drug Information Portal (U.S. National Library of Medicine) - Tripterine PubChem Compound Summary - Celastrol http://www.ebi.ac.uk/ - Celastrol http://www.ncbi.nlm.nih.gov/ - Celastrol http://cancerres.aacrjournals.org/ Chinese Medical Journal
Local | ||
SALES SPECIFICATION | ||
APPEARANCE |
red crystalline powder | |
PURITY | 98.0% min | |
MELTING POINT |
190~ 195 C | |
LOSS ON DRYING | 0.5% max | |
TRANSPORTATION | ||
PACKING | III | |
HAZARD CLASS | 6.1 | |
UN NO. | 2811 | |
SAFETY INFORMATION | ||
HAZARD OVERVIEW |
Toxic if swallowed. May be harmful if inhaled. May cause respiratory tract irritation. May be harmful if absorbed through skin. May cause skin irritation. May cause eye irritation. | |
GHS |
| |
SIGNAL WORD | Warning | |
PICTOGRAMS |
| |
HAZARD STATEMENTS |
H301 | |
P STATEMENTS |
P301 + P310 | |
EC DIRECTIVES |
| |
HAZARD CODES |
T | |
RISK PHRASES |
25 | |
SAFETY PHRASES |
45 |
|